home *** CD-ROM | disk | FTP | other *** search
- Newsgroups: misc.news.southasia
- Path: sparky!uunet!mnemosyne.cs.du.edu!usenet
- From: ww%nyxfer@igc.apc.org (Workers World Service)
- Subject: Indian Firm Produces Cheaper AIDS Treatment Drug
- Message-ID: <1992Dec25.130615.18388@mnemosyne.cs.du.edu>
- Sender: usenet@mnemosyne.cs.du.edu (netnews admin account)
- Organization: The NY Transfer News Service
- Date: Fri, 25 Dec 92 13:06:15 GMT
- Approved: surekha@nyx.cs.du.edu (Surekha Reddy Gaddam)
- Lines: 61
-
-
- Source : The NY Transfer News Service
- Date : Dec 24, 1992
- Country : India
-
- * * * *
-
- * Indian company produces cheaper AZT
-
- By Shishir Thadani
-
- An Indian drug company recently announced it could produce the
- AIDS-treatment drug AZT and market it at one-quarter the cost
- charged to patients in the U.S. But Burroughs-Wellcome, which
- produces and sells AZT in the U.S., has moved to prevent
- pharmacies around the world from purchasing the Indian drug.
-
- Burroughs-Wellcome has threatened the Indian company with a
- patent-violation lawsuit. But Indian patent laws are different
- from those in the U.S. Drugs cannot be patented in India; only
- the chemical processes used to manufacture drugs can be patented.
-
- The Indian company has an original manufacturing process. In
- fact, a company spokesperson said the firm could compete in the
- U.S. market and thus begin higher-volume production.
-
- The drug is already being produced and many Third World countries
- have expressed interest in purchasing it. Some are considering
- setting up local manufacturing plants with the Indian company's
- assistance.
-
- As a goodwill gesture, the Indian government has sent subsidized
- shipments of the drug to other Third World countries. Public
- health officials in Brazil, Thailand and some East African
- countries are following this development with great interest.
-
- But the U.S. government and its imperialist allies in Europe and
- Japan are bringing tremendous pressure on the Indian government
- to change its more progressive patent laws to mirror those in the
- U.S.
-
- Washington's tight patent laws in particular retard technological
- development and competition and hurt consumers. This is
- especially true in the health-care field, and in the case of AIDS
- and other life-threatening illnesses this issue becomes a matter
- of life and death.
-
- If the U.S. government succeeds in its effort to stymie Indian
- production of the drug, it would drastically increase the death
- rate because very few Indians are able to purchase drugs at the
- monopoly prices charged by the imperialist drug cartels.
-
- Health care costs in the U.S. are astronomical, in large part
- because of the patent laws and trade restrictions against
- importing drugs from Third World countries. Shouldn't people with
- AIDS in the U.S. also be permitted to benefit from technological
- developments taking place in India or any other Third World
- country?
-
- * E N D *
-
-